永安药业(002365.SZ)部分董高层拟合计减持不超23.54万股

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) announced that several directors and senior management plan to reduce their shareholding in the company through centralized bidding transactions within three months after a 15 trading day period following the announcement [1] Group 1: Shareholding Details - A total of 942,000 shares are held by the directors and senior management, representing 0.3197% of the total share capital and 0.3258% when excluding shares in the company's repurchase special account [1] - The planned reduction will not exceed 235,400 shares, which is 0.0799% of the total share capital and 0.0814% when excluding shares in the company's repurchase special account [1] Group 2: Control Implications - The share reduction will not lead to a change in the company's control [1]